Prolevi Bio

Limhamn, Sweden

Prolevi Bio develops a delayed release thyroid hormone formulation mimicking the circadian rhythm improving long-term side effects.

$281K raised

Sep 2022

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Prolevi Bio raised?

Prolevi Bio has raised $281K in total funding. The most recent round was Seed. The last funding was announced in September 2022.

Who are Prolevi Bio's investors?

Prolevi Bio's investors include Almi Invest.

Where is Prolevi Bio headquartered?

Prolevi Bio is headquartered in Limhamn, Sweden.

What does Prolevi Bio do?

Prolevi Bio develops a delayed release thyroid hormone formulation mimicking the circadian rhythm improving long-term side effects.

What stage is Prolevi Bio at?

Prolevi Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 14, 2022.

MLA

"Prolevi Bio — Funding & Investors." VCBacked, September 14, 2022, https://www.vcbacked.co/company/prolevi-bio. Accessed July 2, 2026.

APA

VCBacked. (2022). Prolevi Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/prolevi-bio

Wikipedia (cite web)

{{cite web |title=Prolevi Bio — Funding & Investors |url=https://www.vcbacked.co/company/prolevi-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 14, 2022.